We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+27.96%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
AUM
$514M
AUM Growth
-$45.1M
Cap. Flow
-$126M
Cap. Flow %
-24.6%
Top 10 Hldgs %
70.54%
Holding
81
New
6
Increased
6
Reduced
6
Closed
9

Sector Composition

1 Healthcare 19.85%
2 Industrials 14.37%
3 Consumer Discretionary 11.57%
4 Materials 9.88%
5 Financials 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRTS
76
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-169,039
Closed -$448K
DCP
77
DELISTED
DCP Midstream, LP
DCP
-2,848,805
Closed -$31.8M
OIG
78
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-92,514
Closed -$2.29M
FGNA.U
79
DELISTED
FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one
FGNA.U
-500,000
Closed -$5M
HYACW
80
DELISTED
Haymaker Acquisition Corp. II Warrant
HYACW
-333,333
Closed -$330K
AMAG
81
DELISTED
AMAG Pharmaceuticals
AMAG
-1,299,994
Closed -$12.2M

Similar funds

Bleichroeder LP's Q4 2020 Portfolio in Review

As of Q4 2020, Bleichroeder LP held 81 positions worth $514M, down 8.1% from $559M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bleichroeder LP withdrew a net $126M in Q4 2020, closing 9 positions and reducing 6 holdings. Its most notable exit was DCP Midstream, LP, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Bleichroeder LP opened a new position in Healthcare Services Acquisition Corporation Unit worth $1.53M.

  • Bleichroeder LP's largest Q4 2020 buy was Healthcare Services Acquisition Corporation Unit: 150,000 shares worth $1.53M.
  • Bleichroeder LP added most to Brunswick in Q4 2020, an estimated $13.7M increase.
  • Bleichroeder LP's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $38.9M.
  • Bleichroeder LP fully exited DCP Midstream, LP in Q4 2020, selling an estimated $31.8M.
  • Bleichroeder LP's ten largest holdings make up 71% of its $514M portfolio in Q4 2020.
  • Bleichroeder LP opened 6 new positions and closed 9 in Q4 2020.
  • Bleichroeder LP's portfolio value fell 8.1% quarter-over-quarter to $514M.

Based on Bleichroeder LP's 13F filing for Q4 2020, filed 10 Feb 2021.